Australia markets closed

TELA Bio, Inc. (TELA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.3900-0.0600 (-1.35%)
At close: 04:00PM EDT
4.3900 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 108.23M
Enterprise value 102.58M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.72
Price/book (mrq)5.73
Enterprise value/revenue 1.75
Enterprise value/EBITDA -2.52

Trading information

Stock price history

Beta (5Y monthly) 0.95
52-week change 3-53.30%
S&P500 52-week change 321.08%
52-week high 311.2600
52-week low 34.2350
50-day moving average 35.7409
200-day moving average 36.9268

Share statistics

Avg vol (3-month) 3126.45k
Avg vol (10-day) 3232.67k
Shares outstanding 524.65M
Implied shares outstanding 624.65M
Float 815.79M
% held by insiders 12.54%
% held by institutions 186.82%
Shares short (15 Apr 2024) 4925.98k
Short ratio (15 Apr 2024) 45.77
Short % of float (15 Apr 2024) 46.40%
Short % of shares outstanding (15 Apr 2024) 43.76%
Shares short (prior month 15 Mar 2024) 4719.61k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -79.83%
Operating margin (ttm)-72.23%

Management effectiveness

Return on assets (ttm)-37.76%
Return on equity (ttm)-281.23%

Income statement

Revenue (ttm)58.45M
Revenue per share (ttm)2.56
Quarterly revenue growth (yoy)46.30%
Gross profit (ttm)N/A
EBITDA -43.27M
Net income avi to common (ttm)-46.66M
Diluted EPS (ttm)-2.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)46.73M
Total cash per share (mrq)1.9
Total debt (mrq)42.77M
Total debt/equity (mrq)226.50%
Current ratio (mrq)4.23
Book value per share (mrq)0.77

Cash flow statement

Operating cash flow (ttm)-40.86M
Levered free cash flow (ttm)-25.81M